Loading...

Deep learning company Enlitic, partners with Paiyipai across China

Image

04-Apr-17 The American medical deep learning company Enlitic has agreed to cooperate with healthcare big data company Beijing Hao Yun Dao Information & Technology ("Paiyipai") to provide diagnostic imaging in Health Check centers across China. The partnership was agreed following a successful 10,000 chest x-ray trial of Enlitic's patient triage platform. [image: Enlitic]

Read More

Ericsson eyes Healthcare IoT in China with China Mobile, AstraZeneca

Image

27-Mar-17 Ericsson has partnered with China Mobile and AstraZeneca to connect healthcare equipment using NB-IoT technology. China Mobile’s Jiangsu branch and Ericsson will work together to trial new applications using cellular IoT technologies like NB-IoT and provide network terminal management to support equipment management. Additionally, AstraZeneca is also working with the Wuxi government to open a China Commercial Innovation Center. [image: Wireless Week / Ericsson].

Read More

Chinese pharma companies are quietly catching up

Image

31-Mar-17 Without much press or international recognition, Chinese companies have been making good progress enhancing their pharmaceutical and healthcare prowess. For example, in the past few years, 50+ Chinese pharmaceutical companies have entered or completed phase I and phase II clinical trials, while 10+ companies have completed phase III trials. [image: China Money Network

Read More

China’s private hospitals struggle to attract top physicians

Image

27-Mar-17 China’s healthcare sector has long been favoured by investors. However, a shortage of doctors could hinder growth and dent the country’s drive to reform its public healthcare system. “Large public hospitals are reluctant for doctors to leave their posts as they have spent so much time and resources to cultivate them,” said Li Bin, CEO of Ally Bridge LB Healthcare Fund. [image: AP / South China Morning Post]

Read More

Israeli ophthalmic device company EyeYon Medical raises USD6.5 mn

Image

21-Mar-17 Israel's EyeYon Medical has raised USD6.5 mn to develop, test, and seek regulatory approval for its two main solutions: EndoArt, an artificial endothelial layer which can replace the need for cadaver based implants, and Hyper CLTM, a therapeutic soft contact lens. The investment was led by China-based VC Rimonci Capital and Gauss Group, with existing investors Triventures and Pontifax. [image: Globes]

Read More